NewsBenzingaChardan Capital Maintains Buy on Camp4 Therapeutics, Lowers Price Target to $6 Chardan Capital Maintains Buy on Camp4 Therapeutics, Lowers Price Target to $6 Benzinga 2026.09.29 12:11 (GMT+0) Open on Benzinga Other news AI agent security firm Reco raises another $55 million, bringing total funding to $140 million What You Need To Know Ahead of Fastenal's Earnings Release Amaze Holdings (NYSE: AMZE) Executes Binding LOI to Acquire BullionFX | Alchemy, a Decentralized Gold-Backed Financial Ecosystem for Valued at US$155 Million Citi Launches AI Market Guide for Custody Clients What You Need To Know Ahead of U.S. Bancorp’s Earnings Release Temporary Weakness in Intellia Stock Seems Like a Buying Opportunity
Amaze Holdings (NYSE: AMZE) Executes Binding LOI to Acquire BullionFX | Alchemy, a Decentralized Gold-Backed Financial Ecosystem for Valued at US$155 Million
